Medivir in brief

Medivir is a pharmaceutical company focusing on the development of innovative treatments for cancer. To do this efficiently and with a high success rate, we bring together a unique combination of clinical development skills, a collaborative culture and an extensive industry experience, with a balanced project portfolio.

Medivir is listed on Nasdaq Stockholm's Small Cap list.

Read about our current projects